Berry Global Group has declared the capital investment in its global meltblown nonwoven fabric capacity for South America. The investment further strengthens the company's global reach and position as the top nonwovens manufacturer. This line is Berry's first meltblown asset, dependent on its Meltex technology, to be located in South America and proceeds to encourage the requirement for wellness and health products.

With ongoing demand for face masks globally, Berry has been operating closely with customers to help ensure production and supply. The investment will deliver more than 400 metric tons of Meltex meltblown nonwoven material to the area, which will enable the production of more than 500 million surgical-grade masks each year.

"The new asset will be usable at the March 2021 quarter, will soon be placed in a current Berry production facility in South America, and will concentrate on the production of materials for ASTM L2, L3, and N95 masks. The line will be updated with Berry's patented charging tech post-installation," the company said.

"We're pleased to present this state-of-the-art meltblown capability to the South American market. As customers prepare for future outbreaks or protection requirements, we will be ready to function," said Daniel Guerrero, EVP & GM for Latin America in Health, Hygiene, and Specialties at Berry.

As a top global manufacturer of protective nonwovens for health care, Berry makes substances for the world's leading and emerging brands. These protective healthcare apparel (PPE) to packaging, many of which have been deemed vital in the efforts to fight the spread of COVID-19.